IgA nephropathy epidemiology and demographics: Difference between revisions
(Created page with "__NOTOC__ {{IgA nephropathy }} {{CMG}} ==Overview== ==References== {{reflist|2}} {{WH}} {{WS}} Category:Nephrology Category:Genetic disorders") |
|||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
==Epidemiology and Demographics== | |||
Men are affected three times as often as women. There is also a striking geographic variation in the prevalence of IgA nephropathy throughout the world. It is the most common glomerular disease in the Far East and Southeast Asia, comprising almost half of all the patients with glomerular disease. However, it comprises only about 25% of the proportion in European and about 10% among North Americans, with African–Americans having a very low prevalence of about 2%. A confounding factor in this analysis is the existing policy of [[screening]] and use of kidney [[needle aspiration biopsy|biopsy]] as an investigative tool. School children in Japan undergo routine [[urinalysis]] (as do Army recruits in Singapore) and any suspicious abnormality is pursued with a kidney biopsy, which might partly explain the high [[incidence]] of IgA nephropathy in those countries. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 22:04, 27 September 2012
|
IgA nephropathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
IgA nephropathy epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of IgA nephropathy epidemiology and demographics |
|
Risk calculators and risk factors for IgA nephropathy epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Epidemiology and Demographics
Men are affected three times as often as women. There is also a striking geographic variation in the prevalence of IgA nephropathy throughout the world. It is the most common glomerular disease in the Far East and Southeast Asia, comprising almost half of all the patients with glomerular disease. However, it comprises only about 25% of the proportion in European and about 10% among North Americans, with African–Americans having a very low prevalence of about 2%. A confounding factor in this analysis is the existing policy of screening and use of kidney biopsy as an investigative tool. School children in Japan undergo routine urinalysis (as do Army recruits in Singapore) and any suspicious abnormality is pursued with a kidney biopsy, which might partly explain the high incidence of IgA nephropathy in those countries.